Global Herpes Simplex Virus Infections Market to Reach $6.6 Billion by 2030

NEW YORK, Feb. 15, 2023 /PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Read the full report: https://www.reportlinker.com/p06051282/?utm_source=PRN

Global Herpes Simplex Virus Infections Market to Reach $6.6 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Herpes Simplex Virus Infections estimated at US$4.8 Billion in the year 2022, is projected to reach a revised size of US$6.6 Billion by 2030, growing at a CAGR of 3.9% over the period 2022-2030.

The U.S. Market is Estimated at $1.3 Billion, While China is Forecast to Grow at 6.6% CAGR

The Herpes Simplex Virus Infections market in the U.S. is estimated at US$1.3 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 6.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 3.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Select Competitors (Total 13 Featured)

- Admedus Limited

- Agenus Inc.

- Aicuris Anti-infective Cures Gmbh

- Asahi Kasei Corporation

- Chimerix Inc.

- Clinigen Group Plc

- Daewoong Pharmaceutical Co., Ltd.

- F. Hoffmann-la Roche Ltd.

- Glaxosmithkline Plc

- Maruho Co. Ltd.

- Merck

- Mylan

- Novartis

- Sanofi Pasteur

- Teva Pharmaceutical Industries Ltd.

Read the full report: https://www.reportlinker.com/p06051282/?utm_source=PRN

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights

World Market Trajectories

Herpes Simplex Virus Infections - Global Key Competitors

Percentage Market Share in 2022 (E)

Impact of Covid-19 and a Looming Global Recession

Competitive Market Presence - Strong/Active/Niche/Trivial for

Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Geographic Region - USA,

Canada, Japan, China, Europe, Asia-Pacific, Latin America,

Middle East and Africa Markets - Independent Analysis of Annual

Sales in US$ Million for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Herpes Simplex Virus

Infections by Geographic Region - USA, Canada, Japan, China,

Europe, Asia-Pacific, Latin America, Middle East and Africa

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2012 through 2021 and % CAGR

Table 3: World 18-Year Perspective for Herpes Simplex Virus

Infections by Geographic Region - Percentage Breakdown of Value

Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,

Latin America, Middle East and Africa Markets for Years 2012,

2023 & 2030

Table 4: World Herpes Simplex Virus Infections Market Analysis

of Annual Sales in US$ Million for Years 2012 through 2030

III. MARKET ANALYSIS

UNITED STATES

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in the United States

for 2023 (E)

Table 5: USA Recent Past, Current & Future Analysis for Herpes

Simplex Virus Infections by Segment - Herpes Simplex Virus

Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 6: USA Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

CANADA

Table 7: Canada Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 8: Canada Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

JAPAN

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)

Table 9: Japan Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 10: Japan Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

CHINA

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in China for 2023 (E)

Table 11: China Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 12: China Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

EUROPE

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)

Table 13: Europe Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Geographic Region - France,

Germany, Italy, UK, Spain, Russia and Rest of Europe Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2022 through 2030 and % CAGR

Table 14: Europe Historic Review for Herpes Simplex Virus

Infections by Geographic Region - France, Germany, Italy, UK,

Spain, Russia and Rest of Europe Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 15: Europe 18-Year Perspective for Herpes Simplex Virus

Infections by Geographic Region - Percentage Breakdown of Value

Sales for France, Germany, Italy, UK, Spain, Russia and Rest of

Europe Markets for Years 2012, 2023 & 2030

FRANCE

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in France for 2023 (E)

Table 16: France Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 17: France Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

GERMANY

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)

Table 18: Germany Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 19: Germany Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

ITALY

Table 20: Italy Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 21: Italy Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

UNITED KINGDOM

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in the United Kingdom

for 2023 (E)

Table 22: UK Recent Past, Current & Future Analysis for Herpes

Simplex Virus Infections by Segment - Herpes Simplex Virus

Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 23: UK Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

SPAIN

Table 24: Spain Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 25: Spain Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

RUSSIA

Table 26: Russia Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 27: Russia Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

REST OF EUROPE

Table 28: Rest of Europe Recent Past, Current & Future Analysis

for Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 29: Rest of Europe Historic Review for Herpes Simplex

Virus Infections by Segment - Herpes Simplex Virus Infections

Markets - Independent Analysis of Annual Sales in US$ Million

for Years 2012 through 2021 and % CAGR

ASIA-PACIFIC

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in Asia-Pacific for

2023 (E)

Table 30: Asia-Pacific Recent Past, Current & Future Analysis

for Herpes Simplex Virus Infections by Geographic Region -

Australia, India, South Korea and Rest of Asia-Pacific Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2022 through 2030 and % CAGR

Table 31: Asia-Pacific Historic Review for Herpes Simplex Virus

Infections by Geographic Region - Australia, India, South Korea

and Rest of Asia-Pacific Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 32: Asia-Pacific 18-Year Perspective for Herpes Simplex

Virus Infections by Geographic Region - Percentage Breakdown of

Value Sales for Australia, India, South Korea and Rest of

Asia-Pacific Markets for Years 2012, 2023 & 2030

AUSTRALIA

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in Australia for 2023

(E)

Table 33: Australia Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 34: Australia Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

INDIA

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in India for 2023 (E)

Table 35: India Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 36: India Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

SOUTH KOREA

Table 37: South Korea Recent Past, Current & Future Analysis

for Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 38: South Korea Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

REST OF ASIA-PACIFIC

Table 39: Rest of Asia-Pacific Recent Past, Current & Future

Analysis for Herpes Simplex Virus Infections by Segment -

Herpes Simplex Virus Infections - Independent Analysis of

Annual Sales in US$ Million for the Years 2022 through 2030 and

% CAGR

Table 40: Rest of Asia-Pacific Historic Review for Herpes

Simplex Virus Infections by Segment - Herpes Simplex Virus

Infections Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2012 through 2021 and % CAGR

LATIN AMERICA

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in Latin America for

2023 (E)

Table 41: Latin America Recent Past, Current & Future Analysis

for Herpes Simplex Virus Infections by Geographic Region -

Argentina, Brazil, Mexico and Rest of Latin America Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2022 through 2030 and % CAGR

Table 42: Latin America Historic Review for Herpes Simplex

Virus Infections by Geographic Region - Argentina, Brazil,

Mexico and Rest of Latin America Markets - Independent Analysis

of Annual Sales in US$ Million for Years 2012 through 2021 and

% CAGR

Table 43: Latin America 18-Year Perspective for Herpes Simplex

Virus Infections by Geographic Region - Percentage Breakdown of

Value Sales for Argentina, Brazil, Mexico and Rest of Latin

America Markets for Years 2012, 2023 & 2030

ARGENTINA

Table 44: Argentina Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 45: Argentina Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

BRAZIL

Table 46: Brazil Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 47: Brazil Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

MEXICO

Table 48: Mexico Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 49: Mexico Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

REST OF LATIN AMERICA

Table 50: Rest of Latin America Recent Past, Current & Future

Analysis for Herpes Simplex Virus Infections by Segment -

Herpes Simplex Virus Infections - Independent Analysis of

Annual Sales in US$ Million for the Years 2022 through 2030 and

% CAGR

Table 51: Rest of Latin America Historic Review for Herpes

Simplex Virus Infections by Segment - Herpes Simplex Virus

Infections Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2012 through 2021 and % CAGR

MIDDLE EAST

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in Middle East for 2023

(E)

Table 52: Middle East Recent Past, Current & Future Analysis

for Herpes Simplex Virus Infections by Geographic Region -

Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2022 through 2030 and % CAGR

Table 53: Middle East Historic Review for Herpes Simplex Virus

Infections by Geographic Region - Iran, Israel, Saudi Arabia,

UAE and Rest of Middle East Markets - Independent Analysis of

Annual Sales in US$ Million for Years 2012 through 2021 and %

CAGR

Table 54: Middle East 18-Year Perspective for Herpes Simplex

Virus Infections by Geographic Region - Percentage Breakdown of

Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of

Middle East Markets for Years 2012, 2023 & 2030

IRAN

Table 55: Iran Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 56: Iran Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

ISRAEL

Table 57: Israel Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 58: Israel Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

SAUDI ARABIA

Table 59: Saudi Arabia Recent Past, Current & Future Analysis

for Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 60: Saudi Arabia Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

UNITED ARAB EMIRATES

Table 61: UAE Recent Past, Current & Future Analysis for Herpes

Simplex Virus Infections by Segment - Herpes Simplex Virus

Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 62: UAE Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

REST OF MIDDLE EAST

Table 63: Rest of Middle East Recent Past, Current & Future

Analysis for Herpes Simplex Virus Infections by Segment -

Herpes Simplex Virus Infections - Independent Analysis of

Annual Sales in US$ Million for the Years 2022 through 2030 and

% CAGR

Table 64: Rest of Middle East Historic Review for Herpes

Simplex Virus Infections by Segment - Herpes Simplex Virus

Infections Markets - Independent Analysis of Annual Sales in

US$ Million for Years 2012 through 2021 and % CAGR

AFRICA

Herpes Simplex Virus Infections Market Presence - Strong/

Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)

Table 65: Africa Recent Past, Current & Future Analysis for

Herpes Simplex Virus Infections by Segment - Herpes Simplex

Virus Infections - Independent Analysis of Annual Sales in US$

Million for the Years 2022 through 2030 and % CAGR

Table 66: Africa Historic Review for Herpes Simplex Virus

Infections by Segment - Herpes Simplex Virus Infections Markets -

Independent Analysis of Annual Sales in US$ Million for Years

2012 through 2021 and % CAGR

IV. COMPETITION

Read the full report: https://www.reportlinker.com/p06051282/?utm_source=PRN

About Reportlinker

ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

Contact Clare: [email protected]

US: (339)-368-6001

Intl: +1 339-368-6001

SOURCE Reportlinker